Idt Australia Limited · ASX:IDT

Idt Australia — Shareholder Meeting (October 2018)

11 slides from Idt Australia's shareholder meeting presentation, Oct 22, 2018

  1. Slide 1: IDT Australia Limited 2018 Annual General Meeting

    IDT Australia Limited 2018 Annual General Meeting

  2. Slide 2: Safe Harbour

    Safe Harbour This presentation contains forward looking statements which are subject to risks and uncertainties. Such statements involve known and unknown risks. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and there

  3. Slide 3: Year In Review: Key Events

    Year In Review Key Events Refined and Articulated Strategy Changes in Executive Leadership Focus on Operations and Execution • Strategic and Operational Review • Jim Sosic VP Operations and • Implemented Sales and Operations Plan • Selected generics strategy and focus on Infrastructure • Key focus a

  4. Slide 4: Financial Results 2018 Executive Summary

    Financial Results 2018 Executive Summary Revenue growth  FY`18 reported revenue up 39% year on year to $13.3m (FY`17 total revenue $9.5m)  Active pharmaceutical ingredient manufacturing up 127% year on year  Contract manufacturing up 6% with a strong forward order book including medicinal cannabi

  5. Slide 5: Financial Results 2018 Financial Highlights

    Financial Results 2018 Financial Highlights A$000 FY18 FY17 % Change 2H FY18 1H FY18 % Change Revenue from ordinary activities 13,300 9,543 39% 8,311 4,989 67% Operating expenses 11,302 11,414 -1% 5,980 5,322 12% Underlying profit / (Loss)* (2,835) (6,881) -59% 223 (3,058) -107% Cash reserves $14,02

  6. Slide 6: Year on Year Performance: Revenue Growth and Cost Containment

    Year on Year Performance Revenue Growth and Cost Containment Strong revenue growth  Total turnover CAGR 34% (FY`14-18)  FY`18 closing cash position $14.0m Containment of operating costs  Operating expenses CAGR 6% (FY`14- FY`18)  Arrested year on year cost increases Underlying profit/loss  Oper

  7. Slide 7: Looking Ahead: Focus on Operational Leverage and Profitability

    Looking Ahead Focus on Operational Leverage and Profitability Demonstrated operational leverage  2H versus 1H FY`18 showed a $3.32m increase in revenues matched with appreciably lower increases in operating costs and cost of goods.  Cost base for FY`19 and beyond to benefit from full year salary s

  8. Slide 8: Shareholder Buy-backs: Improved Capital Management

    Shareholder Buy-backs Improved Capital Management On Market 10/12 Buy-back  Initiated an equal access on market share buy-back of up to 10% of IDT’s issued capital.  Buy-back in place for up to 12 months commencing on 10 October 2018.  Quantum, timing and price of shares to be bought back is depe

  9. Slide 9: IDT Corporate Snapshot

    IDT Corporate Snapshot One Year Trading Chart 18.5 cents 6.5 cents Oct 2017 Oct 2018  Shares on issue (19 Oct 2018) 243,906,105  Options Nil  Top twenty holders 65.4% of IC  Share price (19 Oct 2018) $0.16  Market cap ~$39m 9  NTA/Share (30 Jun 2018) 12.8 cents

  10. Slide 10: The Year Ahead: Focus on Sustainable and Profitable Business Operations

    The Year Ahead Focus on Sustainable and Profitable Business Operations Drive and Grow the Business  Focus on and grow IDT’s Contract Manufacturing and Commercial API business streams  Focus on execution, maximising facility utilization to restore IDT as a sustainable and profitable business Expans

  11. Slide 11: Dr David Sparling, Chief Executive Officer

    Dr David Sparling Chief Executive Officer T: 0417721972

IDT Australia — Shareholder Meeting (October 2018) on 6ix